AI eye scanner could catch glaucoma before it steals your sight

NCT ID NCT07550712

Completed Diagnosis Sponsor: Acer Medical Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an AI tool called VeriSee GLC that analyzes color images of the back of the eye to find signs of glaucoma. Researchers looked at 773 adults' existing eye images to see how well the AI could identify people who might have glaucoma, comparing its results to a panel of eye experts. The goal is to give doctors a reliable screening tool to catch glaucoma earlier and refer patients for a full exam.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: VeriSee GLC (AI software for analyzing eye images)
What this could lead to: If successful, this AI tool could help eye doctors quickly identify people who might have glaucoma, leading to earlier referral and treatment.
What could go wrong: This was a retrospective study using existing images, not a real-world test. The AI is meant to assist, not replace a doctor, and may not work as well in all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma ocular hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Locations

National Taiwan University Hospital

Taipei, 100, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.